Examples of using Slactive in English and their translations into German
{-}
-
Colloquial
-
Official
-
Ecclesiastic
-
Medicine
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
SLActive® is based on the scientifically proven SLA® topography.
On top of this, nano-structures increase the SLActive® surface area by more than 50%25.
Roxolid® SLActive® narrow diameter implants showed 100% survival rate in the smokers group after 6 months.
SEM imaging of fibrin network formation on Roxolid® SLActive® 15 min incubation with human whole blood.
SLA/SLActive® micro-roughness increases the surface area by at least 100% compared to the machined surface26.
Diabetic patients Clinical evidence shows the high predictability of SLActive® in diabetic patients.4.
Long-term performance of Straumann SLActive bone level dental implants after immediate provisionalization.
SLActive® is associated with an increased anti-inflammatory macrophage response in the early healing phase in both healthy and diabetic animals.
Transgingival versus submerged healing of Straumann SLActive Bone Level implants and the effect of bone level changes.
ROXOLID SLActive® is a high-performance alloy composed of approximately 15% zirconium and 85% titanium, specifically designed by Straumann for use in implant dentistry.
One system with one kit that can be used for all indications and a unique portfolio of different materials and surfaces,including groundbreaking technologies such as Roxolid® and SLActive®.
Distinct nano-structures recently discovered on the SLActive® surface, prove for the first time, that the SLActive® surface topography differs from that of SLA.®.
The latest in-vitro research suggests that hydrophilicity alone does not fully explain the accelerated osseointegration associated with the SLActive® surface properties.
Indeed, SLActive® with nano-structures shows a higher level of fibrin network formation and bone cell mineralization compared to SLActive® without nano-structures(in vitro). 23,24.
New data indicates that nanostructures on the SLActive® surface support fibrin network formation and mineralization, thus facilitating the early phases of osseointegration.
A new clinical study19 that compared SLActive® performance in patients with and without diabetes showed uncompromised performance of SLActive® implants.
Irradiated patients In a randomized clinical trial, SLActive® implants in irradiated patients showed a success rate of 100% after 1-year1 and 5-year2, 3 follow-ups.
With surface and material innovations like Straumann® SLActive® 1(reduced healing time) and Roxolid® 2(smaller implants) the restorative solution can be adapted according to your specific requirements and needs.
The combination of its highly innovative design with Roxolid® and SLActive® creates a unique next-generation implant system that offers a new level of confidence- not just for immediacy, but also for a broad range of other indications.